Clinical impact Target clinics and hospitals with cervical cancer screening programs by highlighting DYSIS’ demonstrated 44% increase in detection of high-grade lesions when using DYSISmap for biopsy selection, showcasing potential to improve diagnostic yield and patient outcomes.

Portable solution Leverage the DYSIS View compact and portable colposcope to offer mobile or satellite clinics, expanding reach into rural or underserved areas and enabling faster adoption in existing imaging workflows.

Digital integration Position the SMARTtrack comparative patient reports and high-resolution imaging workflows as a value-add to electronic medical records and patient communication protocols, facilitating documentation efficiency and treatment planning.

Strategic partnerships Engage with early adopters and opinion leaders in gynecology and oncology, and target institutions with established cervical cancer screening programs to accelerate adoption of computer-aided colposcopy and mapping technology.

Growth potential Capitalize on funding and revenue growth signals with a mid-market profile and a proven revenue stream, aligning outreach to healthcare distributors, hospital systems, and regional integrators to scale commercialization.